HSP60-KD reduced tumor volumes and weights (Supplementary Fig. 8B–G) and increased total CD4+ T cells and CD8+ T cells, including IFNγ+ CD8+ T cells and GZMB+ CD8+ T cells (Supplementary Fig. 8H–K). This evidence concerns the gene CD8A and neoplasm.